| 5/14/2026 | Inceptionr LLC | 5,753 | $334K | 0.1% | N/A | 0.004% | |
| 5/14/2026 | Sei Investments Co. | 33,545 | $1.95M | 0.0% | +8.4% | 0.023% | |
| 5/13/2026 | Cetera Investment Advisers | 9,595 | $558K | 0.0% | +23.1% | 0.007% | |
| 5/7/2026 | Meeder Advisory Services Inc. | 8,335 | $484K | 0.0% | +2.9% | 0.006% | |
| 5/7/2026 | WCM Investment Management LLC | 112,631 | $6.19M | 0.0% | N/A | 0.078% | |
| 5/7/2026 | Dimensional Fund Advisors LP | 375,772 | $21.84M | 0.0% | +95.9% | 0.260% | |
| 5/7/2026 | Parallel Advisors LLC | 1,694 | $98K | 0.0% | +189.1% | 0.001% | |
| 5/7/2026 | Swiss National Bank | 233,100 | $13.55M | 0.0% | +1.2% | 0.161% | |
| 5/6/2026 | Jennison Associates LLC | 1,698,011 | $98.67M | 0.1% | +150.6% | 1.176% | |
| 5/6/2026 | California Public Employees Retirement System | 151,555 | $8.81M | 0.0% | +4.8% | 0.105% | |
Get the Latest News and Ratings for PCVX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vaxcyte and its competitors with MarketBeat's FREE daily newsletter.
|
| 5/6/2026 | Financiere des Professionnels Fonds d investissement inc. | 18,600 | $1.08M | 0.1% | N/A | 0.013% | |
| 5/6/2026 | Allspring Global Investments Holdings LLC | 6,469 | $378K | 0.0% | +10.6% | 0.004% | |
| 5/5/2026 | Marks Group Wealth Management Inc | 6,558 | $381K | 0.0% | N/A | 0.005% | |
| 5/5/2026 | Bank of New York Mellon Corp | 474,526 | $27.58M | 0.0% | +5.6% | 0.329% | |
| 5/5/2026 | Sanctuary Advisors LLC | 6,264 | $364K | 0.0% | +34.2% | 0.004% | |
| 5/4/2026 | Principal Financial Group Inc. | 5,275 | $307K | 0.0% | +7.0% | 0.004% | |
| 5/1/2026 | Fifth Third Bancorp | 2,205 | $128K | 0.0% | N/A | 0.002% | |
| 5/1/2026 | Candriam S.C.A. | 315,022 | $18.31M | 0.1% | N/A | 0.218% | |
| 4/30/2026 | Hsbc Holdings PLC | 3,992 | $232K | 0.0% | -48.8% | 0.003% | |
| 4/30/2026 | Sumitomo Mitsui Trust Group Inc. | 7,331 | $426K | 0.0% | -11.5% | 0.005% | |
| 4/28/2026 | Abel Hall LLC | 6,463 | $376K | 0.1% | N/A | 0.004% | |
| 4/25/2026 | Strs Ohio | 30,800 | $1.79M | 0.0% | +199.0% | 0.021% | |
| 4/22/2026 | Pictet Asset Management Holding SA | 700,311 | $40.70M | 0.0% | -20.5% | 0.487% | |
| 4/22/2026 | Sterling Capital Management LLC | 4,139 | $241K | 0.0% | -37.4% | 0.003% | |
| 4/20/2026 | Blue Trust Inc. | 469 | $27K | 0.0% | -59.7% | 0.000% | |
| 4/20/2026 | Assenagon Asset Management S.A. | 1,164,813 | $67.69M | 0.1% | +113.8% | 0.809% | |
| 4/17/2026 | Values First Advisors Inc. | 6,617 | $385K | 0.2% | +41.4% | 0.005% | |
| 4/17/2026 | Capital Advisors Ltd. LLC | 1,000 | $58K | 0.0% | N/A | 0.001% | |
| 4/16/2026 | SG Americas Securities LLC | 32,212 | $1.87M | 0.0% | +57.7% | 0.022% | |
| 3/20/2026 | Hsbc Holdings PLC | 7,798 | $363K | 0.0% | -84.6% | 0.005% | |
| 3/3/2026 | Caitong International Asset Management Co. Ltd | 830 | $38K | 0.0% | +1,924.4% | 0.001% | |
| 2/26/2026 | Seven Fleet Capital Management LP | 25,365 | $1.17M | 0.9% | N/A | 0.019% | |
| 2/19/2026 | T. Rowe Price Investment Management Inc. | 11,296,333 | $521.21M | 0.3% | +35.9% | 8.629% | |
| 2/19/2026 | Invesco Ltd. | 141,220 | $6.52M | 0.0% | -21.1% | 0.108% | |
| 2/19/2026 | Alberta Investment Management Corp | 30,100 | $1.39M | 0.0% | N/A | 0.023% | |
| 2/18/2026 | Vident Advisory LLC | 8,821 | $407K | 0.0% | +12.9% | 0.007% | |
| 2/18/2026 | Mackenzie Financial Corp | 7,174 | $325K | 0.0% | -10.4% | 0.005% | |
| 2/18/2026 | ADAR1 Capital Management LLC | 315,642 | $14.56M | 1.1% | +48.1% | 0.241% | |
| 2/18/2026 | Empowered Funds LLC | 4,576 | $211K | 0.0% | N/A | 0.003% | |
| 2/18/2026 | XTX Topco Ltd | 15,261 | $704K | 0.0% | N/A | 0.012% | |
Peptide Company Lands Exclusive MMA Wellness Partnership (Ad) A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform tied to Conor McGregor and Dana White - reaching millions of combat sports and biohacking followers worldwide.
On April 15, RFK Jr. announced the FDA would remove 12 peptides from restricted Category 2 status. This company was already selling products tied to three of those peptides - and has developed a patent-pending transdermal patch addressing the 63.2% of adults with needle phobia. The peptide therapeutics market is projected to reach $294 billion by 2033. Read the full report on this small-cap peptide company now |
| 2/18/2026 | Ikarian Capital LLC | 378,682 | $17.47M | 1.4% | +18.8% | 0.289% | |
| 2/18/2026 | Virtus Investment Advisers LLC | 5,979 | $276K | 0.1% | +81.1% | 0.005% | |
| 2/18/2026 | Wellington Management Group LLP | 5,966,310 | $275.29M | 0.1% | +18.5% | 4.558% | |
| 2/18/2026 | SummitTX Capital L.P. | 14,869 | $686K | 0.0% | +123.3% | 0.011% | |
| 2/18/2026 | Tang Capital Management LLC | 275,000 | $12.69M | 0.6% | -8.3% | 0.210% | |
| 2/18/2026 | Twinbeech Capital LP | 78,239 | $3.61M | 0.3% | -65.7% | 0.060% | |
| 2/18/2026 | Progeny 3 Inc. | 23,300 | $1.08M | 0.1% | N/A | 0.018% | |
| 2/18/2026 | Readystate Asset Management LP | 131,637 | $6.07M | 0.2% | N/A | 0.101% | |
| 2/18/2026 | Odyssean LLC | 16,182 | $747K | 0.5% | N/A | 0.012% | |
| 2/18/2026 | Millennium Management LLC | 424,294 | $19.58M | 0.0% | -55.3% | 0.324% | |
| 2/18/2026 | Man Group plc | 68,913 | $3.18M | 0.0% | -71.9% | 0.053% | |
| 2/18/2026 | Ishara Investments LP | 50,000 | $2.31M | 2.7% | N/A | 0.038% | |
| 2/18/2026 | Janus Henderson Group PLC | 13,387,188 | $617.73M | 0.3% | +2.2% | 10.226% | |
| 2/18/2026 | EcoR1 Capital LLC | 450,000 | $20.76M | 0.9% | N/A | 0.344% | |
| 2/18/2026 | Elmind Capital LP | 291,500 | $13.45M | 4.0% | N/A | 0.223% | |
| 2/18/2026 | Eversept Partners LP | 1,197,722 | $55.26M | 2.8% | -15.8% | 0.915% | |
| 2/18/2026 | Cormorant Asset Management LP | 125,000 | $5.77M | 0.3% | -28.6% | 0.095% | |
| 2/18/2026 | Balyasny Asset Management L.P. | 26,865 | $1.24M | 0.0% | -90.3% | 0.021% | |
| 2/18/2026 | Boothbay Fund Management LLC | 497,740 | $22.97M | 0.3% | +286.7% | 0.380% | |
| 2/17/2026 | Guggenheim Capital LLC | 34,501 | $1.59M | 0.0% | -2.6% | 0.026% | |
| 2/17/2026 | Logos Global Management LP | 650,000 | $29.99M | 1.8% | +4.0% | 0.497% | |
| 2/17/2026 | Caligan Partners LP | 1,704,815 | $78.66M | 6.5% | N/A | 1.302% | |
| 2/17/2026 | ADAR1 Capital Management LLC | 315,642 | $14.56M | 1.1% | +48.1% | 0.241% | |
| 2/17/2026 | AQR Capital Management LLC | 14,762 | $681K | 0.0% | N/A | 0.011% | |
| 2/17/2026 | Cetera Investment Advisers | 7,797 | $360K | 0.0% | -8.2% | 0.006% | |
| 2/17/2026 | Lazard Asset Management LLC | 64,978 | $3.00M | 0.0% | -45.4% | 0.050% | |
| 2/17/2026 | RA Capital Management L.P. | 10,724,599 | $494.83M | 5.1% | -10.4% | 8.192% | |
| 2/17/2026 | Paradigm Biocapital Advisors LP | 4,068,020 | $187.70M | 4.8% | +7.5% | 3.107% | |
| 2/17/2026 | Amundi | 5,090 | $235K | 0.0% | N/A | 0.004% | |
| 2/17/2026 | Jump Financial LLC | 89,822 | $4.14M | 0.1% | -53.1% | 0.069% | |
| 2/17/2026 | Farallon Capital Management LLC | 5,000 | $231K | 0.0% | N/A | 0.004% | |
| 2/17/2026 | Price T Rowe Associates Inc. MD | 1,175,339 | $54.23M | 0.0% | -30.4% | 0.898% | |
| 2/17/2026 | T. Rowe Price Investment Management Inc. | 6,682,676 | $308.34M | 0.3% | -19.6% | 5.105% | |
| 2/17/2026 | Rock Springs Capital Management LP | 47,000 | $2.17M | 0.1% | +323.4% | 0.036% | |
| 2/17/2026 | Osaic Holdings Inc. | 3,441 | $159K | 0.0% | -19.5% | 0.003% | |
| 2/17/2026 | Quantitative Investment Management LLC | 8,222 | $379K | 0.0% | N/A | 0.006% | |
| 2/17/2026 | Adage Capital Partners GP L.L.C. | 1,725,000 | $79.59M | 0.1% | +418.0% | 1.318% | |
| 2/17/2026 | California State Teachers Retirement System | 110,862 | $5.12M | 0.0% | +1.3% | 0.085% | |
| 2/17/2026 | Diadema Partners LP | 22,972 | $1.06M | 0.2% | -89.5% | 0.018% | |
| 2/17/2026 | Russell Investments Group Ltd. | 16,455 | $759K | 0.0% | -3.0% | 0.013% | |
| 2/17/2026 | State of Wisconsin Investment Board | 68,285 | $3.15M | 0.0% | -10.8% | 0.052% | |
| 2/17/2026 | Artisan Partners Limited Partnership | 304,049 | $14.03M | 0.0% | N/A | 0.232% | |
| 2/17/2026 | Fred Alger Management LLC | 57,808 | $2.67M | 0.0% | +27.3% | 0.044% | |
| 2/17/2026 | Royal Bank of Canada | 9,224 | $426K | 0.0% | -99.0% | 0.007% | |
| 2/17/2026 | Persistent Asset Partners Ltd | 5,334 | $246K | 0.1% | -89.3% | 0.004% | |
| 2/17/2026 | Polar Capital Holdings Plc | 1,672,783 | $77.18M | 0.3% | +302.6% | 1.278% | |
| 2/17/2026 | Alberta Investment Management Corp | 30,100 | $1.39M | 0.0% | N/A | 0.023% | |
| 2/16/2026 | Spruce Street Capital LP | 400,360 | $18.47M | 6.1% | N/A | 0.306% | |
| 2/16/2026 | Vanguard Personalized Indexing Management LLC | 25,224 | $1.16M | 0.0% | +59.1% | 0.019% | |
| 2/16/2026 | Verition Fund Management LLC | 15,731 | $726K | 0.0% | -62.4% | 0.012% | |
Before you buy SpaceX shares, consider this alternative approach (Ad) SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history.
But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered. Discover the overlooked SpaceX IPO strategy before the June listing |
| 2/16/2026 | Mariner LLC | 8,539 | $394K | 0.0% | +10.1% | 0.007% | |
| 2/16/2026 | NEXTBio Capital Management LP | 95,485 | $4.41M | 2.6% | N/A | 0.073% | |
| 2/16/2026 | Eventide Asset Management LLC | 917,115 | $42.31M | 0.7% | +141.8% | 0.701% | |
| 2/16/2026 | Barclays PLC | 296,195 | $13.67M | 0.0% | -24.8% | 0.226% | |
| 2/16/2026 | Brown Advisory Inc. | 566,925 | $26.16M | 0.0% | -16.3% | 0.433% | |
| 2/13/2026 | Maverick Capital Ltd. | 1,354,237 | $62.48M | 0.7% | +5.0% | 1.034% | |
| 2/13/2026 | The Manufacturers Life Insurance Company | 108,445 | $4.97M | 0.0% | -20.8% | 0.083% | |
| 2/13/2026 | CANADA LIFE ASSURANCE Co | 13,403 | $619K | 0.0% | +17.9% | 0.010% | |
| 2/13/2026 | Segall Bryant & Hamill LLC | 193,423 | $8.93M | 0.1% | +4.7% | 0.148% | |
| 2/13/2026 | Walleye Capital LLC | 14,805 | $683K | 0.0% | N/A | 0.011% | |